Growth inhibition and apoptosis induction by alternol in pancreatic carcinoma cells

被引:0
|
作者
Pei-Fang Cong [1 ]
Ying-Chun Qu [1 ]
Jie-Peng Chen [2 ]
Li-Li Duan [2 ]
Cheng-Jiang Lin [1 ]
Xiao-Lin Zhu [1 ]
Jesse Li-Ling [3 ]
Mei-Xia Zhang [1 ]
机构
[1] Laboratory of Metabolic Disease Research and Drug Development, China Medical University
[2] Strand Biotechnology Institute of Research  3. Nanchuan Institute of Biological Research, Joint Key Laboratory for Bio-resource Research and Utilization of Sichuan and Chongqing
关键词
Pancreatic cancer; Alternol; Chemotherapy; Cell cycle; Apoptosis;
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
100214 ;
摘要
AIM: To investigate the effect of alternol on pancreatic cancer cells.METHODS: Pancreatic cancer cells PANC-1 and Bx PC3 were treated with various concentrations of alternol for 24, 48 and 72 h. Cell proliferation was measured by cell counting. Cell cycle distribution and mitochondrial membrane potential were determined by flow cytometry. Apoptosis was determined by a Td T-mediated d UTP nick end labeling assay and Hoechst staining. Expression of caspase 3, Bcl-2, p53 and p21 was measured by western blotting.RESULTS: Alternol showed dose- and time-dependent inhibition of the proliferation of PANC-1 and Bx PC3 cells in vitro. Alternol induced apoptosis and cell cycle arrest at S phase and decreased mitochondrial membrane potential. Alternol activated caspase 3, upregulated p53 and p21 expression, and downregulated Bcl-2 expression in a dose-dependent manner.CONCLUSION: Our results suggested that alternol is a candidate for treatment of pancreatic cancer.
引用
收藏
页码:4526 / 4535
页数:10
相关论文
共 50 条
  • [1] Growth inhibition and apoptosis induction by alternol in pancreatic carcinoma cells
    Cong, Pei-Fang
    Qu, Ying-Chun
    Chen, Jie-Peng
    Duan, Li-Li
    Lin, Cheng-Jiang
    Zhu, Xiao-Lin
    Li-Ling, Jesse
    Zhang, Mei-Xia
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (15) : 4526 - 4535
  • [2] Growth inhibition and apoptosis induction of tanshinone Ⅱ-A on human hepatocellular carcinoma cells
    Shu-Lan Yuan Yu.Quan Wei Xiu-Jie Wang Fei Xiao Sheng-Fu Li Jie Zhang
    World Journal of Gastroenterology, 2004, (14) : 2024 - 2028
  • [3] ALTERNOL SENSITIZES RENAL CARCINOMA CELLS TO TRAIL-INDUCED APOPTOSIS
    Ren, Yu
    Huang, Shuaishuai
    Wang, Xue
    Yao, Xuping
    Weng, Guobin
    JOURNAL OF UROLOGY, 2018, 199 (04): : E955 - E955
  • [4] Induction of growth inhibition and apoptosis in pancreatic cancer cells by auristatin-PE and gemcitabine
    Li, YW
    Singh, B
    Ali, N
    Sarkar, FH
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1999, 3 (06) : 647 - 653
  • [5] Alternol Sensitizes Renal Carcinoma Cells to TRAIL-Induced Apoptosis
    Ren, Yu
    Wang, Xue
    Huang, Shuaishuai
    Xu, Yangkai
    Weng, Guobin
    Yu, Rui
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [6] Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells
    Yuan, Shu-Lan
    Wei, Yu-Quan
    Wang, Xiu-Jie
    Xiao, Fei
    Li, Sheng-Fu
    Zhang, Jie
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (14) : 2024 - 2028
  • [7] Growth inhibition and apoptosis induction in ovarian cancer cells
    Touma, Rania
    Kartarius, Sabine
    Harlozinska, Antonina
    Goetz, Claudia
    Montenarh, Mathias
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 29 (02) : 481 - 488
  • [8] Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo
    Schwock, Joerg
    Pham, Nhu-An
    Cao, Mary P.
    Hedley, David W.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (04) : 669 - 681
  • [9] Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo
    Jörg Schwock
    Nhu-An Pham
    Mary P. Cao
    David W. Hedley
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 669 - 681
  • [10] Induction of growth inhibition and apoptosis in prostate cancer cells by flavopiridol
    Li, YW
    Chinni, SR
    Senderowicz, AM
    Sarkar, FH
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 17 (04) : 755 - 759